Wednesday, 16 Oct 2019

You are here

Nailfold Capillary Density Predicts Dermatomyositis Lung Involvement

In patients with juvenile dermatomyositis (DM), an association was seen between low nailfold capillary density and pulmonary involvement, European researchers reported.

Among patients whose nailfold capillary density was less than 6/mm, forced vital capacity (FVC) was 89.7% predicted compared with 98.5% predicted for those with normal capillary density (P=0.008), according to Helga Sanner, MD, PhD, of Oslo University Hospital in Norway, and colleagues.

In addition, total lung capacity (TLC) was 87.8% predicted in those with low capillary density compared with 94.5% (P=0.020), while low diffusion capacity for carbon monoxide (DLCO) was found in 71% compared with 38% of those with normal density (P=0.014), the researchers reported online in Arthritis Care & Research.

"Nailfold capillaroscopy is a simple, noninvasive technique to evaluate the microvascular architecture," they wrote.

Studies of adult patients with systemic sclerosis have found associations between abnormalities of the microvasculature detected on nailfold capillaroscopy and pulmonary or cardiac involvement, but no studies thus far have considered the possibility of these associations in pediatric rheumatic diseases such as juvenile DM.

Sanner's group has established a long-term cohort of 58 Norwegian patients diagnosed with juvenile DM from 1970 to 2006 who have been closely followed with nailfold capillaroscopy and pulmonary/cardiac assessments. In previous reports, the team noted that their patients had smaller lung volumes and lower diffusion capacity than healthy controls, along with decreased systolic and diastolic function.

Almost two-thirds of the cohort were female, and mean age at the time of the current analysis was 25.4; disease duration was 17 years.

Pulmonary function was assessed with spirometry, and high-resolution computed tomography (CT) was used to detect interstitial lung disease or other abnormalities such as bronchiectasis. Cardiac assessment included echocardiography and electrocardiography.

Nailfold capillaroscopy found that 36% of patients had low capillary density and identified a neovascular pattern in 41%.

Along with decreased capacity on pulmonary function testing, 30% of patients with low capillary density showed evidence of airway disease on high-resolution CT compared with only 8% of those with normal density (P=0.034).

After adjustment for the association between capillary density and age and disease duration, an association between TLC % predicted and capillary density persisted (β = 0.295, P=0.018), although the association with FVC % predicted did not.

On cardiac measures, no significant differences were observed between patients with low and normal nailfold capillary density, including ECG findings, heart rate variability, and systolic or diastolic function.

"Our key finding is the relationship between low nailfold capillary density and smaller lung volumes (FVC and TLC) and reduced gas diffusion (low DLCO) in juvenile DM," the authors wrote.

They noted that their study found decreased lung volumes and a higher incidence of airways disease detected on high-resolution CT, but a sizeable number of patients whose capillary density was normal also had pulmonary abnormalities.

"Thus, even if microvascular involvement seems to be relevant in the development of pulmonary manifestations, other factors are likely to contribute to the process in juvenile DM."

Subclinical cardiac involvement has been detected in up to one-quarter of patients with juvenile DM, but the study does not support the hypothesis that vasculopathy is the underlying mechanism, the researchers said, noting, though, that the study was too small to provide definitive conclusions on this.

"Further and preferably larger studies are needed to identify nailfold capillary density as a potential biomarker for organ involvement," the researchers concluded.

 

Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

Warfarin Superior to Xarelto in Antiphospholipid Syndrome

A 3 year, multicenter, European, study shows that rivaroxaban was inferior to warfarin in preventing thrombosis in patients with antiphospholipid syndrome (APS) according to the Annals of Internal Medicine. Thus despite the inconvenience of warfarin, it remains the best option for patients with APS.

Declining Trends in Antineutrophil Cytoplasmic Autoantibody–Associated Vasculitis Mortality in the USA

Annals of Internal Medicine reports that age-adjusted mortality rates for antineutrophil cytoplasmic autoantibody–associated vasculitides (AAV) have improved over time - with a decline of nearly 2 percent per year in the United States from 1999 to 2017. Nevertheless, long-term outcomes continue to lag behind mortality rates of the general population.

Serum Interferon Predicts Lupus Flares

Elevated serum levels of interferon-α among patients whose systemic lupus erythematosus (SLE) was in remission helped predict future disease flares, European researchers found.

Among 254 SLE patients who were in remission, 26% had abnormally high serum levels of interferon-α at baseline, according to Alexis Mathian, MD, of Pitié-Salpêtrière Hospital in Paris, and colleagues.

ILD Patients At Risk for Autoimmune Disease

Patients diagnosed with interstitial pneumonia with autoimmune features (IPAF) are at an increased risk of developing a systemic autoimmune rheumatic disease (ARD).

A retrospective study of interstitial lung disease (ILD) patients from the Columbia University Irving Medical Center (2009 to 2017) looked for those who did or did not meet IPAF criteria.

MMWR: Increased Opioid Use in Lupus

Opioids are generally not indicated for pain in systemic lupus erythematosus (SLE) and other rheumatic diseases because of limited efficacy and risks for preference and adverse health effects.